Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Los Angeles Times
Los Angeles Times
Business
Tracey Lien

Uber gets serious with newly created safety advisory board

Nov. 24--In a sign that on-demand transportation company Uber is maturing, the San Francisco company announced Tuesday the creation of a safety advisory board to help it navigate safety and security hurdles.

The six-member board is made up of outsiders such as former Boston Police Commissioner Ed Davis; former deputy executive director of the Texas Department of Transportation John Barton; and National Network to End Domestic Violence executive vice president Cindy Southworth. They will advise Uber's internal safety and security teams.

The board's areas of expertise include physical safety of drivers and passengers, data security, and ways of working with local law enforcement.

SIGN UP for the free California Inc. business newsletter >>

"Throughout my careers as I've focused on tech security and safety, one of the things I've always known is you can't do it alone, especially with emerging tech and the evolution of products going so quickly," said Uber's first chief security officer, Joe Sullivan, who joined Uber eight months ago. Prior to Uber, Sullivan held similar posts at Facebook and eBay.

"You always need to look at it from a lot of different perspectives. [For example], John Barton is going to give me a perspective on highway safety that I don't have. Cindy is going to give me a perspective on sexual assault [that I don't have]."

Uber has faced no shortage of safety and security challenges over the last 12 months. On the data side, a security breach announced in February may have affected up to 50,000 Uber drivers in California. On the passenger safety side, it has continued to take flak from the San Francisco and Los Angeles district attorneys, as well as the taxi and limousine industry over the effectiveness of its driver background checks.

ALSO

Start-up app Purple fills up gas tanks for time-crunched customers

Pfizer and Allergan's $160-billion pharmaceutical merger puts new twist on tax-avoiding inversions

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.